Direct Links to important GMP Excipient Guidelines

The IPEC Qualification of Excipient for Pharmaceutical Use 2008

This document provides guidance on how to qualify pharmaceutical excipients.

more

The Joint IPEC-PQG Good Manufacturing Practices Audit Guideline 2008

This document provides standards for audits in Excipients production sites

more

The Joint IPEC-PQG Good Manufacturing Practices Guideline 2017

This document provides guidance for appropriate GMP standards in the manufacture of pharmaceutical excipients.

more

The IPEC Good Distribution Practices Audit Guideline 2011

This document describes standards for Good Distribution Practice Audits of pharmaceutical excipients.

more

The IPEC Good Distribution Practices Guideline 2006

This document provides guidance Good Distribution Practices for pharmaceutical excipients.

more

Eudralex Volume 3 CHMP/CAT position statement on Creutzfeldt-Jakob disease and advanced therapy medicinal products

The composition of ATMPs may include components of human origin (either as active ingredient, excipients, or raw materials used in their manufacture) and, therefore, the risk of transmitting CJD or vCJD agents has to be considered. Current status of related guidelines

more

The IPEC Excipient Stability Program Guide 2010

This document provides guidance for establishing a stability study program for a pharmaceutical excipient.

more

FDA Guidance for Industry: Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products

This guidance provides the pharmaceutical industry with the Center for Drug Evaluation and Research’s (CDER’s) current thinking on the potential human health risks associated with exposure to dibutyl phthalate (DBP) and di(2-ethylhexyl) phthalate (DEHP

more

Eudralex Volume 3 Questions and answers on cyclodextrins in the context of the revision of the guideline on 'Excipients in the label and package leaflet of medicinal products for human use' (CPMP/463/00 Rev.1)

more

Eudralex Volume 3 Questions & answers on propylene glycol and esters in the context of the revision of the guideline on 'Excipients in the label and package leaflet of medicinal products for human use' (CPMP/463/00 Rev.1)

more

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK